Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) Covid BioResource Collaboration, Wang, Jun, Kotagiri, P., Lyons, P., Al-Lamki, R., Mescia, F., Bergamaschi, L., Turner, L., Morgan, M., Calero-Nieto, F., Bach, K., Mende, N., Wilson, N., Watts, E., Maxwell, P., Chinnery, P., Kingston, N., Papadia, S., Stirrups, K., Walker, N., Gupta, R., Menon, D., Allinson, K., Aitken, S., Toshner, M., Weekes, M., Nathan, J., Walmsley, S., Ouwehand, W., Kasanicki, M., Göttgens, B., Marioni, J., Smith, K., Pober, J. & Bradley, J. 2022, 'Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19', iScience, 25(3), article no: 103971. https://doi.org/10.1016/j.isci.2022.103971